Top Story

TURQUOISE-II: Demographics, viral factors did not predict SVR after 3D regimen

November 21, 2014

BOSTON — Sustained virologic response rates after treatment with an all-oral regimen of coformulated ABT-450 boosted with ritonavir, ombitasvir and dasabuvir plus ribavirin were high in patients with hepatitis C virus genotype 1 infection and cirrhosis across a broad range of subgroups and regardless of baseline characteristics.

Michael W. Fried, MD, professor of medicine and director of the University of North Carolina Liver Center, presented new data from the TURQUOISE-II study at The Liver Meeting.

Wouter Hollander, MD Meeting News Coverage

Associations between H. pylori, asthma, related diseases in children differed across ethnic groups

November 21, 2014
Helicobacter pylori positivity was associated with physician-diagnosed asthma in children up to age 6 years, but had an inverse association with ever wheezing and…

EMA panel recommends approval of DAA regimen for patients with HCV

November 21, 2014
The European Committee for Medicinal Products for Human Use, or CHMP, granted a positive opinion for the recommendation of Viekirax plus Exviera, with or without…
In the Journals

HIV, STIs prevalent among male sex workers in Mexico City

November 21, 2014
HIV and other sexually transmitted infections were common among Mexican male sex workers, according to recent data. Omar Galárraga, PhD, of Brown University…
Adam Hersh In the Journals

Black children more likely to receive narrow-spectrum antibiotics for otitis media

November 21, 2014
Black children diagnosed with otitis media during an ambulatory care visit were more likely to receive guideline-recommended narrow-spectrum antibiotics than nonblack…
More News Headlines »
CME
HCV Consults: Volume 1, Number 3

HCV Consults: Volume 1, Number 3

This activity is supported by educational grants from AbbVie and Genentech, Inc.

More »
Meeting News Coverage Video
thumbnail for video 3895262652001

Early liver transplantation could improve survival rates for patients with alcoholic hepatitis

November 17, 2014
BOSTON — Ibrahim A. Hanouneh, MD, hepatologist at Cleveland Clinic, discussed results of a study that compared…
More »
CME
J490 Challenges in HIV Screening

Challenges in HIV Screening and Prophylaxis: PrEP’ing for the Future

This activity is supported by an educational grant from Gilead Sciences Medical Affairs.

A substantial proportion of Americans with HIV remain undiagnosed and suboptimally treated. Failure to follow…
More »
morganatic-roan
morganatic-roan